Defining Minimum Essential Factors to Derive Highly Pure Human Endothelial Cells from iPS/ES Cells in an Animal Substance-Free System

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Yu Ting ^a   Yu, I Shing ^b   Tsai, Kuen Jer ^a   Shih, Chien Yu ^a   Hwang, Shiaw Min ^c   Su, Ih Jen ^d   Chiang, Po Min ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN;

AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; MESODERM; METABOLISM; MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM; MICE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS; WNT PROTEINS;

EID: 84927605609     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09718     Document Type: Article

References (57)

1. Girard, J.-P., Moussion, C. & Förster, R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12, 762-773 (2012).
2. Zhao, Z. & Zlokovic, B. V. Blood-Brain Barrier: A Dual Life of MFSD2A? Neuron 82, 728-730 (2014).
3. Lilly, B. We Have Contact: Endothelial Cell-Smooth Muscle Cell Interactions. Physiology 29, 234-241 (2014).
4. Badylak, S. F., Taylor, D. & Uygun, K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu. Rev. Biomed. Eng. 13, 27-53 (2011).
5. Fan, Y. et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann. Neurol. 67, 488-497 (2010).
6. Young, A., Lakey, J., Murray, A., Mullen, J. & Moore, R. In vitro senescence occurring in normal human endothelial cells can be rescued by ectopic telomerase activity. Transplant. Proc. 35, 2483-2485 (2003).
7. James, D. et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF [beta] inhibition is Id1 dependent. Nat. Biotechnol. 28, 161-166 (2010).
8. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801 (2009).
9. Ludwig, T. E. et al. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187 (2006).
10. Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424-429 (2011).
11. Unger, C., Skottman, H., Blomberg, P., Dilber, M. S. & Hovatta, O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet. 17, R48-R53 (2008).
12. Honn, K. V., Singley, J. A. & Chavin, W. Fetal bovine serum: a multivariate standard. Exp. Biol. Med. 149, 344-347 (1975).
13. Nishikawa, S.-I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. & Kodama, H. Progressive lineage analysis by cell sorting and culture identifies FLK1+ VEcadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 125, 1747-1757 (1998).
14. Cerdan, C. et al. Activin A promotes hematopoietic fated mesoderm development through upregulation of Brachyury in human embryonic stem cells. Stem Cells Dev. 21, 2866-2877 (2012).
15. Kraushaar, D. C. et al. Heparan sulfate facilitates FGF and BMP signaling to drive mesoderm differentiation of mouse embryonic stem cells. J. Biol. Chem. 287, 22691-22700 (2012).
16. Sturgeon, C. M., Ditadi, A., Awong, G., Kennedy, M. & Keller, G. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat. Biotechnol. 32, 554-561 (2014).
17. Prasain, N. et al. Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells. Nat. Biotechnol. 32, 1151-1157 (2014).
18. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
19. Park, C. et al. A hierarchical order of factors in the generation of FLK1-and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 131, 2749-2762 (2004).
20. White, M. P. et al. Limited Gene Expression Variation inHuman Embryonic Stem Cell and Induced Pluripotent Stem Cell-Derived Endothelial Cells. Stem Cells 31, 92-103 (2013).
21. Oida, T. & Weiner, H. L. Depletion of TGF-β from fetal bovine serum. J. Immunol. Methods 362, 195-198 (2010).
22. Vukicevic, S. et al. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp. Cell Res. 202, 1-8 (1992).
23. Zhou, X., Sasaki, H., Lowe, L., Hogan, B. L. & Kuehn, M. R. Nodal is a novel TGF-β-like gene expressed in the mouse node during gastrulation. Nature 361, 543-547 (1993).
24. Huelsken, J. et al. Requirement for β-catenin in anterior-posterior axis formation in mice. J. Cell Biol. 148, 567-578 (2000).
25. Lian, X. et al. Efficient Differentiation of Human Pluripotent Stem Cells to Endothelial Progenitors via Small-Molecule Activation of WNT Signaling. Stem Cell Reports 3, 804-816 (2014).
26. Chiang, P.-M. & Wong, P. C. Differentiation of an embryonic stem cell to hemogenic endothelium by defined factors: essential role of bone morphogenetic protein 4. Development 138, 2833-2843 (2011).
27. Bennett, C. N. et al. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277, 30998-31004 (2002).
28. Wang, Y. et al. Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene 29, 4658-4670 (2010).
29. Chen, A. et al. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer 14, 552 (2014).
30. Zhu, H. et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc. 5, 550-560 (2010).
31. Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Bio. 7, 131-142 (2006).
32. Teo, A. K. K. et al. Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev. 25, 238-250 (2011).
33. Dixit, N., Maloney, K. M. & Kalonia, D. S. Protein-silicone oil interactions: Comparative effect of nonionic surfactants on the interfacial behavior of a fusion protein. Pharm. Res. 30, 1848-1859 (2013).
34. Barrett, D., Hartshorne, M., Hussain, M., Shaw, P. & Davies, M. Resistance to nonspecific protein adsorption by poly (vinyl alcohol) thin films adsorbed to a poly (styrene) support matrix studied using surface plasmon resonance. Anal. Chem. 73, 5232-5239 (2001).
35. Amiji, M., Park, H. & Park, K. Study on the prevention of surface-induced platelet activation by albumin coating. J. Biomater. Sci. Polym. Ed. 3, 375-388 (1992).
36. De Vries, C. et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991 (1992).
37. Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N. & Williams, L. T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7537 (1993).
38. Meyer, M. et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 18, 363-374 (1999).
39. Olofsson, B. et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. USA 95, 11709-11714 (1998).
40. Park, E. J. et al. An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development 135, 3599-3610 (2008).
41. Dealy, C. N., Seghatoleslami, M. R., Ferrari, D. & Kosher, R. A. FGF-stimulated outgrowth and proliferation of limb mesoderm is dependent on syndecan-3. Dev. Biol. 184, 343-350 (1997).
42. Vereide, D. T. et al. An Expandable, Inducible Hemangioblast State Regulated by Fibroblast Growth Factor. Stem cell reports 3, 1043-1057 (2014).
43. Orlova, V. V. et al. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat. Protoc. 9, 1514-1531 (2014).
44. Kurian, L. et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nat. Methods 10, 77-83 (2013).
45. Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70-78 (2009).
46. Wang, Z. Z. et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 25, 317-318 (2007).
47. Nakao, A. et al. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362 (1997).
48. Kawasaki, K. et al . Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells. J. Cell Biol. 181, 131-141 (2008).
49. Murakami, M. et al. FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 121, 2668-2678 (2011).
50. Goldman, O. et al. A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27, 1750-1759 (2009).
51. Chen, Y. et al. NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239-247 (2008).
52. Candia, A. F. et al. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124, 4467-4480 (1997).
53. Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425, 577-584 (2003).
54. Evseenko, D. et al. Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 107, 13742-13747 (2010).
55. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686 (2007).
56. van Gijlswijk, R. P. et al. Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization. J. Histochem. Cytochem. 45, 375-382 (1997).
57. Ritz, C. & Spiess, A.-N. qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysis. Bioinformatics 24, 1549-1551 (2008).